Proteomics International Laboratories Ltd (PIQ)

Currency in AUD
0.0920
-0.0020(-2.13%)
Closed·
PIQ is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.09200.0940
52 wk Range
0.09000.8600
Key Statistics
Bid/Ask
0.092 / 0.093
Prev. Close
0.092
Open
0.094
Day's Range
0.092-0.094
52 wk Range
0.09-0.86
Volume
112.98K
Average Volume (3m)
119.38K
1-Year Change
-71.6923%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
PIQ Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to grow this year

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Earnings

Latest Release
Aug 31, 2026
EPS / Forecast
-0.02 / --
Revenue / Forecast
2.64M / --
EPS Revisions
Last 90 days

PIQ Income Statement

Compare PIQ to Peers and Sector

Metrics to compare
PIQ
Peers
Sector
Relationship
P/E Ratio
−1.8x−1.0x−0.2x
PEG Ratio
−1.570.010.00
Price/Book
2.6x1.5x2.6x
Price / LTM Sales
4.5x1.6x2.6x
Upside (Analyst Target)
367.4%141.4%77.0%
Fair Value Upside
Unlock0.2%13.7%Unlock

Proteomics International Laboratories Ltd operates as a medical technology company with a focus on the area of proteomics in Australia, New Zealand, the United States, Europe, and India. It provides PromarkerD, a blood test to predict chronic kidney disease in people with type 2 diabetes. The company’s products under development include PromarkerEndo, which has completed clinical validation phase for endometriosis diagnosis; PromarkerEso, which has completed clinical validation trials for esophageal cancer diagnosis; and OxiDx (2-tag), which has completed clinical validation phase for oxidative stress treatment. The company also offers analytical services, such as biomarker discovery and validation, biosimilars/biologics characterisation, and pharmacokinetic testing. It has strategic collaboration with Harry Perkins Institute of Medical Research, Bioplatforms Australia, The University of Western Australia, Australian Research Council Training Centre, and the Australian Centre. Proteomics International Laboratories Ltd was founded in 2001 and is based in Nedlands, Australia.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
10.58M6.40%973.48K
Other Institutional Investors
6.68M4.04%614.87K
Public Companies & Retail Investors
148.11M89.56%13.63M
Total
165.37M100.00%15.21M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Fidelity International Ltd4.46%7,381,299679
Fidelity Funds - Pacific Fund3.37%5,571,921513

FAQ

What Is the PILL (PIQ) Stock Price Today?

The PILL stock price today is 0.0920 AUD.

What Stock Exchange Does PILL Trade On?

PILL is listed and trades on the Sydney Stock Exchange.

What Is the Stock Symbol for PILL?

The stock symbol for PILL is "PIQ."

What Is the PILL Market Cap?

As of today, PILL market cap is 15.2100M AUD.

What Is PILL's Earnings Per Share (TTM)?

The PILL EPS (TTM) is -0.064.

From a Technical Analysis Perspective, Is PIQ a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has PILL Stock Split?

PILL has split 0 times.

What is the current trading status of PILL (PIQ)?

As of Nov 22, 2026, PILL (PIQ) is trading at a price of 0.0920 AUD, with a previous close of 0.0920 AUD. The stock has fluctuated within a day range of 0.0920 AUD to 0.0940 AUD, while its 52-week range spans from 0.0900 AUD to 0.8600 AUD.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.